A Genetic Variant in the Interleukin 28 B Gene Is a Major Predictor for Sustained Virologic Response in Mexican Patients with Chronic Hepatitis C Virus Infection
暂无分享,去创建一个
M. Uribe | I. Garc | L. Amezcua-Guerra | M. Dehesa-Violante | L. Toapanta-Yanchapaxi | Avilaa | M. Sixtos-Alonso | R. Sandoval-Salas | R. Avalos-Martinez | ıa-Juarez | Alejandro Ch | avez-Ayala | S. JuanFrancisco | -. anchez
[1] P. Tangkijvanich,et al. Prevalence of Thymine—Adenine Dinucleotide Repeat, IL28B and IFNL4 in Thai Population and Correlation with Spontaneous Clearance and Treatment Outcome of Hepatitis C Infection , 2015, PloS one.
[2] T. Berg,et al. Predictive Value of Interferon-Lambda Gene Polymorphisms for Treatment Response in Chronic Hepatitis C , 2014, PloS one.
[3] L. Prokunina-Olsson,et al. Association of the IFNL4-ΔG Allele With Impaired Spontaneous Clearance of Hepatitis C Virus. , 2014, The Journal of infectious diseases.
[4] S. Khakoo,et al. Genetic Variation in the Interleukin-28B Gene Is Associated with Spontaneous Clearance and Progression of Hepatitis C Virus in Moroccan Patients , 2013, PloS one.
[5] Barbara Rehermann,et al. A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus , 2013, Nature Genetics.
[6] A. Burguete-García,et al. IL28B polymorphisms predict the response to chronic hepatitis C virus infection treatment in a Mexican population. , 2012, Annals of hepatology.
[7] S. El-Kafrawy,et al. Genetic polymorphism in IL28B is associated with spontaneous clearance of hepatitis C virus genotype 4 infection in an Egyptian cohort. , 2011, The Journal of infectious diseases.
[8] J. Pinho,et al. IL28B polymorphisms are markers of therapy response and are influenced by genetic ancestry in chronic hepatitis C patients from an admixed population , 2011, Liver international : official journal of the International Association for the Study of the Liver.
[9] M. Silva,et al. Genetic variation in interleukin-28B predicts SVR in hepatitis C genotype 1 Argentine patients treated with PEG IFN and ribavirin. , 2011, Annals of hepatology.
[10] Katherine D Gonzalez,et al. IL28B polymorphisms associated with therapy response in Chilean chronic hepatitis C patients. , 2011, World journal of gastroenterology.
[11] F. Negro,et al. Trends and projections of hepatitis C virus epidemiology in Latin America , 2011, Liver international : official journal of the International Association for the Study of the Liver.
[12] C. Thio,et al. IL28B and the control of hepatitis C virus infection. , 2010, Gastroenterology.
[13] M. Romero-Gómez,et al. Interleukin‐28B genetic variants and hepatitis virus infection by different viral genotypes , 2010, Hepatology.
[14] X. Lao,et al. Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin. , 2010, Gastroenterology.
[15] David B. Goldstein,et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus , 2009, Nature.
[16] Jacques Fellay,et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance , 2009, Nature.
[17] D. Kershenobich-Stalnikowitz,et al. Prevalence of hepatitis C virus genotypes in Mexican patients. , 2007, Revista de gastroenterologia de Mexico.
[18] J. Pawlotsky,et al. Hepatitis C virus: virology, diagnosis and management of antiviral therapy. , 2007, World journal of gastroenterology.
[19] T. Poynard,et al. Meta‐analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration , 1996, Hepatology.
[20] R. Vázquez-Frias,et al. Mexican consensus on the diagnosis and management of hepatitis C infection. , 2015, Annals of hepatology.
[21] A ALBORNOZ PLATA,et al. [Epidemiology of viral hepatitis]. , 1951, Pediatria de las Americas.